Stockreport

Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer [Yahoo! Finance]

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com
PDF Trial design allows flexibility to include an experimental arm with checkpoint inhibitor combination SAN DIEGO, November 19, 2025 BUSINESS WIRE )--Oncolytics Biotech [Read more]